Share
Biological Warfare: Role of Salk Institute in Army's Research Program: Nsiad-92-33
U. S. Government Accountability Office ( ; U. S. Government Accountability Office ( (Author)
·
Bibliogov
· Paperback
Biological Warfare: Role of Salk Institute in Army's Research Program: Nsiad-92-33 - U. S. Government Accountability Office ( ; U. S. Government Accountability Office (
Choose the list to add your product or create one New List
✓ Product added successfully to the Wishlist.
Go to My Wishlists
Origin: U.S.A.
(Import costs included in the price)
It will be shipped from our warehouse between
Wednesday, August 14 and
Wednesday, August 21.
You will receive it anywhere in United Kingdom between 1 and 3 business days after shipment.
Synopsis "Biological Warfare: Role of Salk Institute in Army's Research Program: Nsiad-92-33"
Pursuant to a congressional request, GAO reviewed an Army contract laboratory's development and production of vaccines to protect U.S. forces against biological warfare threats, focusing on whether the: (1) contractor developed and produced vaccines against biological agents recognized and validated as warfare threats; (2) contractor was the Army's only viable means of developing and producing such vaccines; and (3) contractor's fees for the use of its facilities complied with applicable federal regulations. GAO found that: (1) the contractor spent 17 percent of the $17.7 million in Army payments on work clearly related to biological agents validated as warfare threats; (2) the contractor spent 33 percent of payments on work that applied to biological agents and diseases not related to warfare and 50 percent of payments on diseases not related to warfare; (3) commercial vaccine producers indicate that there are not viable alternatives to contracting since there is no commercial market for such vaccines in the United States and vaccine producers lack the facilities needed to produce them; (4) although the Army's current in-house capabilities are not sufficient to meet the demand for biological warfare vaccines, the Army could improve research and expand its research and development laboratories to meet vaccine production needs; and (5) the Army paid the contractor $5.5 million more in fees than applicable federal regulations permitted, by following cost principles for commercial organizations instead of those for nonprofit organizations.
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.
✓ Producto agregado correctamente al carro, Ir a Pagar.
